Next Article in Journal
Identification and Functional Characterization of Genes Encoding Omega-3 Polyunsaturated Fatty Acid Biosynthetic Activities from Unicellular Microalgae
Previous Article in Journal
Activation of the Nuclear Factor E2-Related Factor 2 Pathway by Novel Natural Products Halomadurones A–D and a Synthetic Analogue
Mar. Drugs 2013, 11(12), 5100-5115; doi:10.3390/md11125100

Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia

, 1,* , 1
, 2,3
, 2,3
, 2
, 2,3
, 4
, 4
, 4
, 4
 and 1
Received: 14 October 2013 / Revised: 15 November 2013 / Accepted: 3 December 2013 / Published: 16 December 2013
View Full-Text   |   Download PDF [894 KB, updated 24 February 2015; original version uploaded 24 February 2015]   |   Browse Figures
Abstract: Transient receptor potential vanilloid 1 receptors (TRPV1) play a significant physiological role. The study of novel TRPV1 agonists and antagonists is essential. Here, we report on the characterization of polypeptide antagonists of TRPV1 based on in vitro and in vivo experiments. We evaluated the ability of APHC1 and APHC3 to inhibit TRPV1 using the whole-cell patch clamp approach and single cell Ca2+ imaging. In vivo tests were performed to assess the biological effects of APHC1 and APHC3 on temperature sensation, inflammation and core body temperature. In the electrophysiological study, both polypeptides partially blocked the capsaicin-induced response of TRPV1, but only APHC3 inhibited acid-induced (pH 5.5) activation of the receptor. APHC1 and APHC3 showed significant antinociceptive and analgesic activity in vivo at reasonable doses (0.01–0.1 mg/kg) and did not cause hyperthermia. Intravenous administration of these polypeptides prolonged hot-plate latency, blocked capsaicin- and formalin-induced behavior, reversed CFA-induced hyperalgesia and produced hypothermia. Notably, APHC3’s ability to inhibit the low pH-induced activation of TRPV1 resulted in a reduced behavioural response in the acetic acid-induced writhing test, whereas APHC1 was much less effective. The polypeptides APHC1 and APHC3 could be referred to as a new class of TRPV1 modulators that produce a significant analgesic effect without hyperthermia.
Keywords: sea anemone; analgesic polypeptide APHC; TRPV1 receptor; animal models; temperature regulation; nociception; inflammation sea anemone; analgesic polypeptide APHC; TRPV1 receptor; animal models; temperature regulation; nociception; inflammation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Andreev, Y.A.; Kozlov, S.A.; Korolkova, Y.V.; Dyachenko, I.A.; Bondarenko, D.A.; Skobtsov, D.I.; Murashev, A.N.; Kotova, P.D.; Rogachevskaja, O.A.; Kabanova, N.V.; Kolesnikov, S.S.; Grishin, E.V. Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia. Mar. Drugs 2013, 11, 5100-5115.

AMA Style

Andreev YA, Kozlov SA, Korolkova YV, Dyachenko IA, Bondarenko DA, Skobtsov DI, Murashev AN, Kotova PD, Rogachevskaja OA, Kabanova NV, Kolesnikov SS, Grishin EV. Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia. Marine Drugs. 2013; 11(12):5100-5115.

Chicago/Turabian Style

Andreev, Yaroslav A.; Kozlov, Sergey A.; Korolkova, Yuliya V.; Dyachenko, Igor A.; Bondarenko, Dmitrii A.; Skobtsov, Denis I.; Murashev, Arkadii N.; Kotova, Polina D.; Rogachevskaja, Olga A.; Kabanova, Natalia V.; Kolesnikov, Stanislav S.; Grishin, Eugene V. 2013. "Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia." Mar. Drugs 11, no. 12: 5100-5115.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert